Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Sangamo Therapeutics Analyst Ratings and Price Targets | NASDAQ:SGMO | Benzinga
Sangamo Therapeutics Inc has a consensus price target of $4.72 based on the ratings of 9 analysts. The high is $10 issued by HC Wainwright & Co. on April 7, 2025. The low is $1.5 issued by B of A Securities on April 28, 2023. The 3 most-recent analyst ratings were released by Barclays, HC Wainwright & Co., and RBC Capital on May 14, 2025, April 7, 2025, and March 18, 2025, respectively. With an average price target of $5.67 between Barclays, HC Wainwright & Co., and RBC Capital, there's an implied 1051.29% upside for Sangamo Therapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barclays
HC Wainwright & Co.
RBC Capital
Truist Securities
Jefferies
1calculated from analyst ratings
Analyst Ratings for Sangamo Therapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/14/2025 | Buy Now | 915.85% | Barclays | Gena Wang52% | $9 → $5 | Maintains | Overweight | Get Alert |
| 04/07/2025 | Buy Now | 1931.69% | HC Wainwright & Co. | Patrick Trucchio50% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 03/18/2025 | Buy Now | 306.34% | RBC Capital | Luca Issi45% | $2 → $2 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 01/27/2025 | Buy Now | 1931.69% | HC Wainwright & Co. | Patrick Trucchio50% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 01/23/2025 | Buy Now | 915.85% | Truist Securities | Nicole Germino60% | $7 → $5 | Maintains | Buy | Get Alert |
| 01/02/2025 | Buy Now | 1931.69% | HC Wainwright & Co. | Patrick Trucchio50% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 12/31/2024 | Buy Now | 509.51% | Jefferies | Maury Raycroft33% | $7 → $3 | Maintains | Buy | Get Alert |
| 12/31/2024 | Buy Now | 306.34% | Wells Fargo | Jim Birchenough61% | $3 → $2 | Maintains | Equal-Weight | Get Alert |
| 12/20/2024 | Buy Now | 1931.69% | HC Wainwright & Co. | Patrick Trucchio50% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 12/19/2024 | Buy Now | 1931.69% | HC Wainwright & Co. | Patrick Trucchio50% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 12/10/2024 | Buy Now | 1931.69% | HC Wainwright & Co. | Patrick Trucchio50% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 11/14/2024 | Buy Now | 1931.69% | HC Wainwright & Co. | Patrick Trucchio50% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 11/14/2024 | Buy Now | 1728.52% | Barclays | Gena Wang52% | $3 → $9 | Maintains | Overweight | Get Alert |
| 11/05/2024 | Buy Now | 1931.69% | HC Wainwright & Co. | Patrick Trucchio50% | $5 → $10 | Maintains | Buy | Get Alert |
| 10/23/2024 | Buy Now | 915.85% | HC Wainwright & Co. | Patrick Trucchio50% | $5 → $5 | Reiterates | Buy → Buy | Get Alert |
| 10/22/2024 | Buy Now | 915.85% | HC Wainwright & Co. | Patrick Trucchio50% | $5 → $5 | Reiterates | Buy → Buy | Get Alert |
| 08/22/2024 | Buy Now | 915.85% | HC Wainwright & Co. | Patrick Trucchio50% | $5 → $5 | Reiterates | Buy → Buy | Get Alert |
| 07/31/2024 | Buy Now | 915.85% | HC Wainwright & Co. | Patrick Trucchio50% | $5 → $5 | Reiterates | Buy → Buy | Get Alert |
| 07/24/2024 | Buy Now | 915.85% | HC Wainwright & Co. | Patrick Trucchio50% | $5 → $5 | Reiterates | Buy → Buy | Get Alert |
| 05/15/2024 | Buy Now | 915.85% | HC Wainwright & Co. | Patrick Trucchio50% | $5 → $5 | Reiterates | Buy → Buy | Get Alert |
| 03/19/2024 | Buy Now | 915.85% | HC Wainwright & Co. | Patrick Trucchio50% | $3 → $5 | Reiterates | Buy → Buy | Get Alert |
| 03/14/2024 | Buy Now | 306.34% | RBC Capital | Luca Issi45% | $2 → $2 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 03/13/2024 | Buy Now | 509.51% | HC Wainwright & Co. | Patrick Trucchio50% | $3 → $3 | Maintains | Buy | Get Alert |
| 02/12/2024 | Buy Now | 509.51% | HC Wainwright & Co. | Patrick Trucchio50% | $3 → $3 | Reiterates | Buy → Buy | Get Alert |
| 02/06/2024 | Buy Now | 509.51% | HC Wainwright & Co. | Patrick Trucchio50% | $3 → $3 | Reiterates | Buy → Buy | Get Alert |
| 01/19/2024 | Buy Now | 509.51% | HC Wainwright & Co. | Patrick Trucchio50% | $3 → $3 | Reiterates | Buy → Buy | Get Alert |
| 11/07/2023 | Buy Now | — | Truist Securities | Nicole Germino60% | — | Downgrade | Buy → Hold | Get Alert |
| 11/06/2023 | Buy Now | 509.51% | HC Wainwright & Co. | Patrick Trucchio50% | $5 → $3 | Maintains | Buy | Get Alert |
| 11/06/2023 | Buy Now | 103.17% | Wells Fargo | Jim Birchenough61% | → $1 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/03/2023 | Buy Now | 306.34% | RBC Capital | Luca Issi45% | $6 → $2 | Downgrade | Outperform → Sector Perform | Get Alert |
| 08/15/2023 | Buy Now | 1322.19% | Truist Securities | Nicole Germino60% | $8 → $7 | Maintains | Buy | Get Alert |
| 08/14/2023 | Buy Now | 915.85% | HC Wainwright & Co. | Patrick Trucchio50% | → $5 | Reiterates | Buy → Buy | Get Alert |
| 08/11/2023 | Buy Now | 1931.69% | Wedbush | Andreas Argyrides70% | $16 → $10 | Maintains | Outperform | Get Alert |
| 08/10/2023 | Buy Now | 712.68% | Wells Fargo | Yanan Zhu44% | $5 → $4 | Maintains | Overweight | Get Alert |
| 08/09/2023 | Buy Now | 1728.52% | Barclays | Gena Wang52% | $11 → $9 | Maintains | Overweight | Get Alert |
| 08/09/2023 | Buy Now | 1119.02% | RBC Capital | Luca Issi45% | $8 → $6 | Maintains | Outperform | Get Alert |
| 05/10/2023 | Buy Now | 1525.36% | Truist Securities | Nicole Germino60% | $16 → $8 | Maintains | Buy | Get Alert |
| 05/01/2023 | Buy Now | 915.85% | HC Wainwright & Co. | Patrick Trucchio50% | $15 → $5 | Maintains | Buy | Get Alert |
| 04/28/2023 | Buy Now | 204.75% | B of A Securities | Greg Harrison47% | $5 → $1.5 | Downgrade | Neutral → Underperform | Get Alert |
| 03/03/2023 | Buy Now | 2947.54% | HC Wainwright & Co. | Patrick Trucchio50% | $25 → $15 | Maintains | Buy | Get Alert |
| 02/27/2023 | Buy Now | 3150.71% | Wedbush | Andreas Argyrides70% | → $16 | Upgrade | Neutral → Outperform | Get Alert |
| 02/23/2023 | Buy Now | 2541.2% | RBC Capital | Luca Issi45% | $22 → $13 | Maintains | Outperform | Get Alert |
| 01/04/2023 | Buy Now | 2947.54% | Wells Fargo | Yanan Zhu44% | $20 → $15 | Maintains | Overweight | Get Alert |
| 11/07/2022 | Buy Now | 3963.39% | Wells Fargo | Yanan Zhu44% | $22 → $20 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Sangamo Therapeutics (SGMO) stock?
The latest price target for Sangamo Therapeutics (NASDAQ:SGMO) was reported by Barclays on May 14, 2025. The analyst firm set a price target for $5.00 expecting SGMO to rise to within 12 months (a possible 915.85% upside). 19 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Sangamo Therapeutics (SGMO)?
The latest analyst rating for Sangamo Therapeutics (NASDAQ:SGMO) was provided by Barclays, and Sangamo Therapeutics maintained their overweight rating.
When was the last upgrade for Sangamo Therapeutics (SGMO)?
The last upgrade for Sangamo Therapeutics Inc happened on February 27, 2023 when Wedbush raised their price target to $16. Wedbush previously had a neutral for Sangamo Therapeutics Inc.
When was the last downgrade for Sangamo Therapeutics (SGMO)?
The last downgrade for Sangamo Therapeutics Inc happened on November 7, 2023 when Truist Securities changed their price target from N/A to N/A for Sangamo Therapeutics Inc.
When is the next analyst rating going to be posted or updated for Sangamo Therapeutics (SGMO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sangamo Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sangamo Therapeutics was filed on May 14, 2025 so you should expect the next rating to be made available sometime around May 14, 2026.
Is the Analyst Rating Sangamo Therapeutics (SGMO) correct?
While ratings are subjective and will change, the latest Sangamo Therapeutics (SGMO) rating was a maintained with a price target of $9.00 to $5.00. The current price Sangamo Therapeutics (SGMO) is trading at is $0.49, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
